Hudson Bay Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,600
Closed -$2.12M 1229
2025
Q2
$2.12M Sell
7,600
-165,600
-96% -$46.9M 0.01% 780
2025
Q1
$54M Buy
+173,200
New +$51.1M 0.17% 122
2019
Q1
Sell
-12,500
Closed -$2.43M 684
2018
Q4
$2.43M Buy
+12,500
New +$2.44M 0.03% 466
2018
Q3
Sell
-39,600
Closed -$7.31M 694
2018
Q2
$7.31M Buy
+39,600
New +$7M 0.1% 190
2018
Q1
Sell
-35,000
Closed -$6.09M 763
2017
Q4
$6.09M Buy
+35,000
New +$6.19M 0.13% 134
2013
Q4
Sell
-200,000
Closed -$22.4M 158
2013
Q3
$22.4M Buy
+200,000
New +$21.7M 0.83% 34

Other funds holding AMGN

Hudson Bay Capital Management's AMGN Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 281,000 shares worth $102M. The stake represents 0.28% of the portfolio and ranks #81 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in AMGN as recently as Q2 2025.

Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and has held it in 12 quarters since. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hudson Bay Capital Management held 281,000 shares of Amgen worth $102M as of Q2 2026.
  • Amgen was a new Hudson Bay Capital Management position in Q2 2026.
  • Amgen made up 0.28% of Hudson Bay Capital Management's portfolio in Q2 2026, its #81 holding.
  • Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and has held it in 12 quarters since.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.